Last week, Kate and I hopped over the pond to attend the Glanzmann’s Research Foundation’s (GRF) first ever educational conference…
Last year, the first gene therapy to treat severe haemophilia A was granted ‘conditional marketing authorisation’ in Europe (basically, fast-track…
The International Society for Thrombosis and Haemostasis (ISTH) is an organisation of clinicians and scientists sharing new discoveries, enhanced understanding…
In a recent paper in The Journal of Haemophilia Practice, Tyler Buckner and colleagues describe the development of ‘ATHN 7’.…
There is always a sense of anticipation among Haemnet’s publications team when we receive the annual report for The Journal…
For International Nurses Day 2023, I’m delighted that The Journal of Haemophilia Practice is publishing the first papers in our Living,…
People whose bleeding disorders are categorised as ‘mild’ (often defined as having between 5% to 40% of usual clotting levels)…
The theme of World Hemophilia Day this year is “Access for All: Prevention of bleeds as the global standard of care”.…
The treatment options available to people with haemophilia have expanded rapidly in recent years. With gene therapies for both…
With the recent licensing of haemophilia gene therapy, it’s no surprise that it was a hot topic at the EAHAD…
On International Women’s Day 2023, Haemnet shines a light on women and girls with bleeding disorders Looking back on…
For far too long, haemophilia has been associated with men. Women have been relegated to being labelled as ‘carriers’ and…